SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Black Spade Acquisition III (BIII) — Dec 4, 2025

Black Spade Acquisition III Co
Date: Dec. 4, 2025 · CIK: 0002087087 · Accession: 0001104659-25-118573

Regulatory Compliance Risk Disclosure Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290602

Referenced dates: December 2, 2025

Date
December 4, 2025
Author
/s/ Sharon Lau
Form
CORRESP
Company
Black Spade Acquisition III Co

Letter

VIA EDGAR Division of Corporation Finance Office of Real Estate & Construction United States Securities and Exchange Commission Attention: Catherine De Lorenzo and Pam Howell Re: Black Spade Acquisition III Co Registration Statement on Form S-1 Filed September 30, 2025 File No. 333-290602

Dear Sir or Madam:

On behalf of our client, Black Spade Acquisition III Co, a blank check company incorporated under the laws of the Cayman Islands as an exempted company with limited liability (the " Company "), we hereby transmit the responses of the Company to the comments provided by the staff (the " Staff ") of the Securities and Exchange Commission (the " Commission ") in its comment letter dated December 2, 2025 (the " Comment Letter ") with respect to the Registration Statement on Form S-1 filed with the Commission on September 30, 2025 (the " Registration Statement "). Concurrently with the filing of this letter, the Company has filed Amendment No. 1 to the Registration Statement on Form S-1 (" Amendment No. 1 ") through EDGAR.

The Staff's comments are repeated below in italic and are followed by the Company's responses. We have included page references to Amendment No. 1 where a response refers to the revised disclosure therein. Capitalized terms used but not otherwise defined herein have the meanings set forth in Amendment No. 1.

December 4, 2025 Page 2

Registration Statement on Form S-1

Cover Page

1. Please state the amount of the compensation received or to be received by the SPAC sponsor, its affiliates, and promoters, the amount of securities issued or to be issued by the SPAC to the SPAC sponsor, its affiliates, and promoters and the price paid or to be paid for such securities. This would include, for example, the $20,000 monthly payment for office space, administrative and support services, the repayment of loans and the payment of consulting, success or finder fees, as referenced in the table on page 6. Provide a cross-reference, highlighted by prominent type or in another manner, to the locations of related disclosures in the prospectus. See Item 1602(a)(3) of Regulation S-K.

Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page of Amendment No. 1.

Summary, page 1

2. Please revise to disclose any actual or potential material conflict of interest between the SPAC sponsor, its affiliates, or promoters; and purchasers in the offering, including those that may arise in determining whether to pursue a de-SPAC transaction, as required by Item 1602(b)(7) of Regulation S-K.

Response: In response to the Staff's comment, the Company has revised the disclosure on pages 14, 41 and 42 of Amendment No. 1.

Risks, page 41

3. Please revise to clearly disclose the risks that being based in China poses to investors. In particular, describe the significant regulatory, liquidity, and enforcement risks with cross-references to the more detailed discussion of these risks in the prospectus. For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of the securities you are registering for sale. Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

Response: The Company respectfully submits that the Registration Statement included disclosure of the risks that being based in China poses to investors, and such disclosure is contained on pages 90 to 107 of Amendment No. 1. In addition, in response to the Staff's comment, the Company has revised the disclosure on pages 15, 44 and 90 of Amendment No. 1.

Proposed Business, page 123

4. We note your disclosure on page 107 regarding the enforcement risks related to civil liabilities due to your sponsor and some of your officers and directors being located in China and Hong Kong. Please identify each officer and director located in China or Hong Kong and disclose that it will be more difficult to enforce liabilities and enforce judgments on those individuals.

Response: In response to the Staff's comment, the Company has revised the disclosure on pages 99 and 109 of Amendment No. 1.

If you have any questions regarding the Registration Statement, please contact Sharon Lau ( sharon.lau@lw.com or +65 6437 5464) or Stacey Wong (stacey.wong@lw.com or +65 6437 5450) of Latham & Watkins LLP.

December 4, 2025 Page 3

Thank you for your time and attention.

Very truly yours,
/s/ Sharon Lau

Show Raw Text
CORRESP
 1
 filename1.htm

 9 Raffles Place

 #42-02 Republic Plaza

 Singapore 048619

 Tel: +65.6536.1161 Fax: +65.6536.1171

 www.lw.com

 UEN No. T09LL1649F

 FIRM / AFFILIATE OFFICES

 Austin
 Milan

 Beijing
 Munich

 Boston
 New York

 Brussels
 Orange County

 December 4, 2025
 Chicago
 Paris

 Dubai
 Riyadh

 Düsseldorf
 San Diego

 Frankfurt
 San Francisco

 Hamburg
 Seoul

 Hong Kong
 Silicon Valley

 Houston
 Singapore

 London
 Tel Aviv

 Los Angeles
 Tokyo

 Madrid
 Washington, D.C.

 VIA EDGAR

 Division of Corporation Finance

 Office of Real Estate & Construction

 United States Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

 Attention: Catherine De Lorenzo and Pam Howell

 Re:
 Black Spade Acquisition III Co

 Registration Statement on Form S-1

 Filed September 30, 2025

 File No. 333-290602

 Dear Sir or Madam:

 On
behalf of our client, Black Spade Acquisition III Co, a blank check company incorporated under the laws of the Cayman Islands as an exempted
company with limited liability (the " Company "), we hereby transmit the responses of the Company to the comments
provided by the staff (the " Staff ") of the Securities and Exchange Commission (the " Commission ")
in its comment letter dated December 2, 2025 (the " Comment Letter ") with respect to the Registration Statement
on Form S-1 filed with the Commission on September 30, 2025 (the " Registration Statement "). Concurrently
with the filing of this letter, the Company has filed Amendment No. 1 to the Registration Statement on Form S-1 (" Amendment
No. 1 ") through EDGAR.

 The
Staff's comments are repeated below in italic and are followed by the Company's responses. We have included page references
to Amendment No. 1 where a response refers to the revised disclosure therein. Capitalized terms used but not otherwise defined herein
have the meanings set forth in Amendment No. 1.

 December 4, 2025
 Page 2

 Registration
Statement on Form S-1

 Cover Page

 1. Please state the amount of the compensation received or to be received by the SPAC sponsor, its affiliates,
and promoters, the amount of securities issued or to be issued by the SPAC to the SPAC sponsor, its affiliates, and promoters and the
price paid or to be paid for such securities. This would include, for example, the $20,000 monthly payment for office space, administrative
and support services, the repayment of loans and the payment of consulting, success or finder fees, as referenced in the table on page 6.
Provide a cross-reference, highlighted by prominent type or in another manner, to the locations of related disclosures in the prospectus.
See Item 1602(a)(3) of Regulation S-K.

 Response:
 In response to the Staff's comment, the Company has revised the disclosure on the cover page of Amendment No. 1.

 Summary, page 1

 2. Please revise to disclose any actual or potential material conflict of interest between the SPAC sponsor,
its affiliates, or promoters; and purchasers in the offering, including those that may arise in determining whether to pursue a de-SPAC
transaction, as required by Item 1602(b)(7) of Regulation S-K.

 Response:
 In response to the Staff's comment, the Company has revised the disclosure on pages 14, 41 and 42 of Amendment
No. 1.

 Risks, page 41

 3. Please revise to clearly disclose the risks that being based in China poses to investors. In particular,
describe the significant regulatory, liquidity, and enforcement risks with cross-references to the more detailed discussion of these risks
in the prospectus. For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding
the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that
the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas
and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of the securities
you are registering for sale. Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over
offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder
your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or
be worthless.

 Response: The
Company respectfully submits that the Registration Statement included disclosure of the risks that being based in China poses to
investors, and such disclosure is contained on pages 90 to 107 of Amendment No. 1. In addition, in response to the
Staff's comment, the Company has revised the disclosure on pages 15, 44 and 90 of Amendment No. 1.

 Proposed Business, page 123

 4. We note your disclosure on page 107 regarding the enforcement risks related to civil liabilities
due to your sponsor and some of your officers and directors being located in China and Hong Kong. Please identify each officer and director
located in China or Hong Kong and disclose that it will be more difficult to enforce liabilities and enforce judgments on those individuals.

 Response:
 In response to the Staff's comment, the Company has revised the disclosure on pages 99 and 109 of Amendment
No. 1.

 If
you have any questions regarding the Registration Statement, please contact Sharon Lau ( sharon.lau@lw.com or +65 6437 5464) or
Stacey Wong (stacey.wong@lw.com or +65 6437 5450) of Latham & Watkins LLP.

 December 4, 2025
 Page 3

 Thank you for your time
and attention.

 Very truly yours,

 /s/ Sharon Lau

 Sharon Lau

 of LATHAM &WATKINS LLP

 Enclosure

 cc:
 (via email)

 Dennis Tam, Executive Chairman and Co-Chief Executive Officer, Black Spade Acquisition III Co

 Kester Ng, Co-Chief Executive Officer and Chief Financial Officer, Black Spade Acquisition III Co

 Richard Taylor, Co-Chief Executive Officer and Chief Operating Officer, Black Spade Acquisition III Co

 Stacey Wong, Partner, Latham & Watkins LLP

 Mitchell S. Nussbaum, Partner, Loeb & Loeb LLP

 David J. Levine , Partner, Loeb & Loeb LLP